---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-107952"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2022-10-12T23:59:59+00:00"
generated_at: "2026-06-23T04:06:43.732848+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics closes $12M offering, net $10.4M; uses proceeds to repurchase InvaGen shares

## Summary
- Closed underwritten offering of 3,636,365 units at $3.30/unit; net proceeds ~$10.4M.
- Proceeds to repurchase all shares held by InvaGen Pharmaceuticals; remainder for working capital.
- Believes it now complies with Nasdaq equity requirement (min $2.5M) and bid price >$1.00 for 13 days.
- Underwriter Aegis Capital Corp. also purchased 545,454 additional warrants via over-allotment.
- Company awaiting formal Nasdaq compliance determination from Panel.

## SEC filing metadata
- accession: 0001104659-22-107952
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2022-10-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465922107952/0001104659-22-107952-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465922107952/tm2228055d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-107952
- JSON: https://secwatch.observer/filing/0001104659-22-107952.json
- Plain text: https://secwatch.observer/filing/0001104659-22-107952.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.